Literature DB >> 30229992

The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome.

Mina Amiri1, Razieh Bidhendi Yarandi1,2, Fatemeh Nahidi3, Maryam Tohidi4, Fahimeh Ramezani Tehrani1.   

Abstract

BACKGROUND AND
OBJECTIVE: While has been well demonstrated that clinical characteristics of polycystic ovary syndrome (PCOS) are associated with an impaired quality of life (QoL) in patients, it is unclear that whether the biochemical aspects of PCOS can influence their QoL. We aimed to investigate the relationship between clinical and biochemical characteristics, and various domains of QoL in patients with PCOS.
DESIGN: A cross-sectional study. PATIENTS AND MEASUREMENTS: We assessed the association between clinical and biochemical characteristics and QoL domains (psychosocial-emotional, fertility, sexual function, and obesity-menstrual) in a total of 211 women with PCOS using a specific health-related quality-of-life questionnaire for PCOS patients.
RESULTS: Our findings showed positive significant association of QoL with age, and its negative significant associations with BMI, hirsutism and infertility (P < 0.05). We also found a negative association between FAI and total QoL (r = -0.14; P = 0.042) and domains of hirsutism (r = -0.14; P = 0.045) and obesity-menstrual (r = -0.23; P = 0.001). DHEAS was positively associated with the sexual function aspect of QoL (r = 0.20; P = 0.043). There were no significant associations between QoL and other hormonal parameters including LH to FSH ratio and total testosterone (tT). Significant associations were found between triglycerides (TG), total cholesterol (TC), LDL and HDL cholesterol, and domain of obesity-menstrual of QoL. HOMA-IR was significantly related to all QoL domains except self-image and hirsutism.
CONCLUSION: Although biochemical markers can influence QoL in patients with PCOS, clinical manifestations of this syndrome such as obesity, infertility and hirsutism seem to play roles in worsening QoL, in particular for psychosocial domains. Hence, clinicians should regularly assess the clinical and psychosocial dimensions of PCOS as well as biochemical aspects.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  hyperandrogenism; infertility; obesity; polycystic ovary syndrome; quality of life

Mesh:

Year:  2018        PMID: 30229992     DOI: 10.1111/cen.13858

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh.

Authors:  Syed Mohammed Basheeruddin Asdaq; Shahamah Jomah; Reem Hasan; Danah Al-Baroudi; Mai Alharbi; Sarah Alsubaie; Maryam Hassan Buhamad; Bdoor Alyahya; Mohammed Jaber Al-Yamani
Journal:  Saudi J Biol Sci       Date:  2020-09-01       Impact factor: 4.219

2.  Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms.

Authors:  Salla Karjula; Laure Morin-Papunen; Stephen Franks; Juha Auvinen; Marjo-Riitta Järvelin; Juha S Tapanainen; Jari Jokelainen; Jouko Miettunen; Terhi T Piltonen
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

3.  The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study.

Authors:  Mohammed Altigani Abdalla; Harshal Deshmukh; Irfaan Mohammed; Stephen Atkin; Marie Reid; Thozhukat Sathyapalan
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

4.  Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation.

Authors:  Michael J Boivin; Farnaz Fatehi; Amy E Phillips-Chan; Julia R Richardson; Amanda N Summers; Steven A Foley
Journal:  BMC Womens Health       Date:  2020-06-23       Impact factor: 2.809

5.  Efficacy of Vitamin D Combined with Metformin and Clomiphene in the Treatment of Patients with Polycystic Ovary Syndrome Combined with Infertility.

Authors:  Lili Zhuang; Wei Cui; Jianxiang Cong; Yinghong Zhang
Journal:  Iran J Public Health       Date:  2019-10       Impact factor: 1.429

6.  Differences in and Correlates of Sexual Function in Infertile Women with and without Polycystic Ovary Syndrome.

Authors:  Azadeh Akbari Sene; Bita Tahmasbi; Farideh Keypour; Hadi Zamanian; Fahimeh Golbabaei; Mohammadali Amini-Tehrani
Journal:  Int J Fertil Steril       Date:  2021-01-19

7.  Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study.

Authors:  Samantha A Neubronner; Inthrani R Indran; Yiong Huak Chan; Angelica Win Pa Thu; Eu-Leong Yong
Journal:  BMC Womens Health       Date:  2021-04-01       Impact factor: 2.809

Review 8.  Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone.

Authors:  Lindsay R Standeven; Elizabeth Olson; Nicole Leistikow; Jennifer L Payne; Lauren M Osborne; Liisa Hantsoo
Journal:  Curr Psychiatry Rep       Date:  2021-04-21       Impact factor: 5.285

9.  The Effective Factors on The Sexual Function of Polycystic Ovary Syndrome Women: A Cross-Sectional Study.

Authors:  Bita Fereidooni; Ensieh Jenabi; Salman Khazaei; Sara Abdoli
Journal:  Int J Fertil Steril       Date:  2022-08-21

10.  Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial.

Authors:  Mina Amiri; Fatemeh Nahidi; Razieh Bidhendi Yarandi; Davood Khalili; Maryam Tohidi; Fahimeh Ramezani Tehrani
Journal:  Health Qual Life Outcomes       Date:  2020-08-31       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.